Analysis of the DMPK gene CTG repeat in healthy Brazilians

Freitas, Silvia Regina Sampaio; Cabello, Pedro H; Moura-Neto, Rodrigo Soares; Duro, Luiz Alves.
Genet. mol. biol ; 30(1): 14-16, 2007. graf, tab
Artigo Inglês | LILACS | ID: lil-445677

Documentos relacionados

  1. CRISPR/Cas Applications in Myotonic Dystrophy: Expanding Opportunities.
  2. Longitudinal increases in somatic mosaicism of the expanded CTG repeat in myotonic dystrophy type 1 are associated with variation in age-at-onset.
  3. DM1 Phenotype Variability and Triplet Repeat Instability: Challenges in the Development of New Therapies.
  4. Treatment of type 1 myotonic dystrophy by engineering site-specific RNA endonucleases that target (CUG)(n) repeats.
  5. Reply: The repeat variant in MSH3 is not a genetic modifier for spinocerebellar ataxia type 3 and Friedreich's ataxia.
  6. The repeat variant in MSH3 is not a genetic modifier for spinocerebellar ataxia type 3 and Friedreich's ataxia.
  7. Expanded CUG repeats in <i>DMPK</i> transcripts adopt diverse hairpin conformations without influencing the structure of the flanking sequences.
  8. Recovery in the Myogenic Program of Congenital Myotonic Dystrophy Myoblasts after Excision of the Expanded (CTG)<i>n</i> Repeat.
  9. Myotonic dystrophy, when simple repeats reveal complex pathogenic entities: new findings and future challenges.
  10. RNA toxicity in human disease and animal models: from the uncovering of a new mechanism to the development of promising therapies.